Compare MP Materials (MP) vs Novartis AG (NVS) Price & Performance

MP MaterialsTrade

Novartis AGTrade

Price performance (Past 24H)

Key statistics

MP Materials vs Novartis AG — how do they compare? MP Materials trades at $46.86 (market cap $8.25B), while Novartis AG trades at $142.74 (market cap $274.00B). The key difference: Novartis AG is far larger — about 33.2× MP Materials's market cap, and Novartis AG pays a 3.31% dividend while MP Materials pays none. Which is the better fit depends on your goals — on Pluang, investors hold MP Materials for 11 Days and Novartis AG for 82 Days on average.

	MP	NVS
Market Cap	$8.25B	$274.00B
Volume	5,934,023	1,852,137
Sector	Basic Materials	Health
52-Week High	$98.65	$168.62
52-Week Low	$38.10	$121.80
Typical Hold Time	11 Days	82 Days
Enterprise Value	$7.73B	$315.32B
Dividend Yield	—	3.31%

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

MP Materials

No Aura AI signal available yet.

Novartis AG

Novartis (NVS) trades at $143.28, up 1.77% today, with mixed technical signals showing neutral momentum. The company demonstrates strong fundamentals with $56.67B revenue in 2025, 22.5% net margin, and consistent earnings beats in recent quarters. Recent developments include a significant $7.8B licensing deal with China's Abogen for mRNA therapy, though offset by clinical trial setbacks in ALS drug development and ongoing investor scrutiny of M&A strategy.

Outlook remains cautiously optimistic with analyst consensus target of $146 suggesting modest upside. Key opportunities include pipeline expansion through strategic partnerships, while risks involve clinical trial failures, M&A integration challenges, and patent cliff pressures. The stock presents a balanced risk-reward profile with strong profitability offset by pipeline execution concerns.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

81% Buy19% Sell

Avg holding period · 11 Days

NVS

100% Buy0% Sell

Avg holding period · 82 Days

Top news

Latest headlines on both assets

Critical metals stocks fall again; builders like USA Rare Earth drop sharply, producers like MP Materials hold better.24/7 Wall Street · 20 hours agoBearish Rare earth stocks drop 3-5% amid sector-wide selloff without company-specific news.24/7 Wall Street · 1 day agoBearish Pentagon invests $400M in MP Materials to break China's rare earth magnet monopoly, GM first to receive non-China magnets.24/7 Wall Street · 4 days agoBullish View details →

NVS

Novartis faces securities fraud probe after drug trial failure causes stock to drop 14%.PRNewsWire · 23 hours agoBearish View details →

About MP Materials

MP Materials mines, refines, and manufactures rare earth materials and magnets in the United States. Its products are used in transportation, energy, robotics, defense, and aerospace applications.

About Novartis AG

Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.